Cargando…
GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation
Dissecting the pathways regulating the adaptive immune response in atherosclerosis is of particular therapeutic interest. Here we report that the lipid G-protein coupled receptor GPR55 is highly expressed by splenic plasma cells (PC), upregulated in mouse spleens during atherogenesis and human unsta...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613934/ https://www.ncbi.nlm.nih.gov/pubmed/36523570 http://dx.doi.org/10.1038/s44161-022-00155-0 |
_version_ | 1783605543345061888 |
---|---|
author | Guillamat-Prats, Raquel Hering, Daniel Derle, Abhishek Rami, Martina Härdtner, Carmen Santovito, Donato Rinne, Petteri Bindila, Laura Hristov, Michael Pagano, Sabrina Vuilleumier, Nicolas Schmid, Sofie Janjic, Aleksandar Enard, Wolfgang Weber, Christian Maegdefessel, Lars Faussner, Alexander Hilgendorf, Ingo Steffens, Sabine |
author_facet | Guillamat-Prats, Raquel Hering, Daniel Derle, Abhishek Rami, Martina Härdtner, Carmen Santovito, Donato Rinne, Petteri Bindila, Laura Hristov, Michael Pagano, Sabrina Vuilleumier, Nicolas Schmid, Sofie Janjic, Aleksandar Enard, Wolfgang Weber, Christian Maegdefessel, Lars Faussner, Alexander Hilgendorf, Ingo Steffens, Sabine |
author_sort | Guillamat-Prats, Raquel |
collection | PubMed |
description | Dissecting the pathways regulating the adaptive immune response in atherosclerosis is of particular therapeutic interest. Here we report that the lipid G-protein coupled receptor GPR55 is highly expressed by splenic plasma cells (PC), upregulated in mouse spleens during atherogenesis and human unstable or ruptured compared to stable plaques. Gpr55-deficient mice developed larger atherosclerotic plaques with increased necrotic core size compared to their corresponding controls. Lack of GPR55 hyperactivated B cells, disturbed PC maturation and resulted in immunoglobulin (Ig)G overproduction. B cell-specific Gpr55 depletion or adoptive transfer of Gpr55-deficient B cells was sufficient to promote plaque development and elevated IgG titers. In vitro, the endogenous GPR55 ligand lysophsophatidylinositol (LPI) enhanced PC proliferation, whereas GPR55 antagonism blocked PC maturation and increased their mitochondrial content. Collectively, these discoveries provide previously undefined evidence for GPR55 in B cells as a key modulator of the adaptive immune response in atherosclerosis. |
format | Online Article Text |
id | pubmed-7613934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76139342022-12-14 GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation Guillamat-Prats, Raquel Hering, Daniel Derle, Abhishek Rami, Martina Härdtner, Carmen Santovito, Donato Rinne, Petteri Bindila, Laura Hristov, Michael Pagano, Sabrina Vuilleumier, Nicolas Schmid, Sofie Janjic, Aleksandar Enard, Wolfgang Weber, Christian Maegdefessel, Lars Faussner, Alexander Hilgendorf, Ingo Steffens, Sabine Nat Cardiovasc Res Article Dissecting the pathways regulating the adaptive immune response in atherosclerosis is of particular therapeutic interest. Here we report that the lipid G-protein coupled receptor GPR55 is highly expressed by splenic plasma cells (PC), upregulated in mouse spleens during atherogenesis and human unstable or ruptured compared to stable plaques. Gpr55-deficient mice developed larger atherosclerotic plaques with increased necrotic core size compared to their corresponding controls. Lack of GPR55 hyperactivated B cells, disturbed PC maturation and resulted in immunoglobulin (Ig)G overproduction. B cell-specific Gpr55 depletion or adoptive transfer of Gpr55-deficient B cells was sufficient to promote plaque development and elevated IgG titers. In vitro, the endogenous GPR55 ligand lysophsophatidylinositol (LPI) enhanced PC proliferation, whereas GPR55 antagonism blocked PC maturation and increased their mitochondrial content. Collectively, these discoveries provide previously undefined evidence for GPR55 in B cells as a key modulator of the adaptive immune response in atherosclerosis. 2022-11 2022-11-11 /pmc/articles/PMC7613934/ /pubmed/36523570 http://dx.doi.org/10.1038/s44161-022-00155-0 Text en https://www.springernature.com/gp/open-research/policies/accepted-manuscript-termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Guillamat-Prats, Raquel Hering, Daniel Derle, Abhishek Rami, Martina Härdtner, Carmen Santovito, Donato Rinne, Petteri Bindila, Laura Hristov, Michael Pagano, Sabrina Vuilleumier, Nicolas Schmid, Sofie Janjic, Aleksandar Enard, Wolfgang Weber, Christian Maegdefessel, Lars Faussner, Alexander Hilgendorf, Ingo Steffens, Sabine GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title | GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title_full | GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title_fullStr | GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title_full_unstemmed | GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title_short | GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation |
title_sort | gpr55 in b cells limits atherosclerosis development and regulates plasma cell maturation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613934/ https://www.ncbi.nlm.nih.gov/pubmed/36523570 http://dx.doi.org/10.1038/s44161-022-00155-0 |
work_keys_str_mv | AT guillamatpratsraquel gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT heringdaniel gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT derleabhishek gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT ramimartina gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT hardtnercarmen gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT santovitodonato gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT rinnepetteri gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT bindilalaura gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT hristovmichael gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT paganosabrina gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT vuilleumiernicolas gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT schmidsofie gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT janjicaleksandar gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT enardwolfgang gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT weberchristian gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT maegdefessellars gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT faussneralexander gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT hilgendorfingo gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation AT steffenssabine gpr55inbcellslimitsatherosclerosisdevelopmentandregulatesplasmacellmaturation |